Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Antibody entities : Amgen inc. save search
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
Bispecific Antibodies for Cancer Market Size to Grow by USD 396.56 million, Emerging Bispecific Antibody Generation Platforms to be Key Trend - Technavio
Published: 2022-09-28 (Crawled : 23:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -0.53%
H: 0.69%
C: 0.31%
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -0.94%
H: 0.29%
C: -3.81%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: -1.05%
H: 0.71%
C: 0.1%
MREO | $2.79 0.0% 790K
|
Health Technology
|
| O: -2.11%
H: 4.64%
C: 1.48%
APVO | $0.7475 5.28% 5.02% 350K
|
Health Technology
|
| O: 0.31%
H: 0.92%
C: -9.23%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -1.36%
AFMD | $5.22 4.4% 4.21% 22K
|
Health Technology
|
| O: -1.41%
H: 0.48%
C: -3.33%
antibody cancer market
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: -4.41%
H: 3.01%
C: 0.79%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -2.85%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -5.18%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: 0.0%
antibody results
Anti-CD20 Monoclonal Antibodies (mABs) Market size to increase by USD 9.05 Bn | 9.0% YOY growth expected in 2022 | Technavio
Published: 2022-05-25 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.42%
H: 2.73%
C: 2.73%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.54%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 1.42%
H: 0.72%
C: 0.0%
cd20 expected growth market antibody
Bispecific Antibodies for Cancer Market will Register 6.44% YOY Growth in 2022 | 39% Growth to Originate from North America| 17,000+ Technavio Reports
Published: 2022-03-09 (Crawled : 08:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -2.55%
H: 1.28%
C: 0.19%
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 8.24%
H: 1.25%
C: -1.99%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 0.5%
H: 5.19%
C: 4.84%
MREO | $2.79 0.0% 790K
|
Health Technology
|
| O: 16.67%
H: 4.76%
C: -0.68%
APVO | $0.7475 5.28% 5.02% 350K
|
Health Technology
|
| O: -2.6%
H: 10.68%
C: 4.31%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.81%
H: 0.13%
C: -1.18%
AFMD | $5.22 4.4% 4.21% 22K
|
Health Technology
|
| O: 2.39%
H: 7.24%
C: 6.07%
america origin report cancer growth antibody
New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
Published: 2021-12-13 (Crawled : 01:00) - prnewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: -3.62%
H: 5.16%
C: 4.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -4.01%
H: 1.01%
C: -2.07%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.22%
H: 1.65%
C: 1.15%
treatment antibody
Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma
Published: 2021-12-11 (Crawled : 20:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
| Email alert
Add to watchlist
results antibody
Global Biosimilar Monoclonal Antibodies (mAbs) Market in Pharmaceuticals Industry|Discover Company Insights in Technavio
Published: 2021-07-24 (Crawled : 00:20) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
monoclonal antibodies antibody biosimilar
Cancer Monoclonal Antibodies Market 2021-2025: Post-Pandemic Industry Planning Structure | Technavio
Published: 2021-07-12 (Crawled : 22:00) - prnewswire.com
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.68%
H: 0.94%
C: 0.87%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.42%
H: 0.55%
C: -0.23%
monoclonal antibodies cancer antibody
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.